New insulin enters first human tests
Disease control
Recruiting now
This is an early-stage study to test a new long-acting insulin called GZR33 in people with type 1 diabetes. It will compare how well GZR33 controls blood sugar and how safe it is compared to an existing insulin (degludec). The study will involve 12 adults to see how the body proc…
Phase: PHASE1 • Sponsor: Gan and Lee Pharmaceuticals, USA • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC